Insider Selling: Omnicell Director Unloads 5,000 Shares of Stock (OMCL)
Omnicell (NASDAQ:OMCL) Director Gary S. Petersmeyer unloaded 5,000 shares of Omnicell stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $26.45, for a total transaction of $132,250.00. Following the sale, the director now directly owns 15,088 shares in the company, valued at approximately $399,078. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
A number of analysts have recently weighed in on OMCL shares. Analysts at Zacks reiterated a “neutral” rating on shares of Omnicell in a research note on Thursday, May 29th. They now have a $28.00 price target on the stock. Separately, analysts at Stephens initiated coverage on shares of Omnicell in a research note on Tuesday, May 20th. They set an “overweight” rating on the stock. Finally, analysts at Cowen and Company raised their price target on shares of Omnicell from $28.00 to $30.00 in a research note on Friday, May 2nd. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $30.83.
Omnicell (NASDAQ:OMCL) traded down 0.99% during mid-day trading on Wednesday, hitting $26.09. The stock had a trading volume of 169,380 shares. Omnicell has a one year low of $18.43 and a one year high of $30.33. The stock has a 50-day moving average of $26.48 and a 200-day moving average of $26.48. The company has a market cap of $955.0 million and a P/E ratio of 35.70.
Omnicell (NASDAQ:OMCL) last announced its earnings results on Thursday, May 1st. The company reported $0.26 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.24 by $0.02. The company had revenue of $101.80 million for the quarter, compared to the consensus estimate of $97.49 million. During the same quarter in the prior year, the company posted $0.21 earnings per share. The company’s quarterly revenue was up 16.9% on a year-over-year basis. Analysts expect that Omnicell will post $1.23 EPS for the current fiscal year.
Omnicell, Inc (NASDAQ:OMCL) is a provider of automated solutions for hospital medication and supply management.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.